A novel nuclear imaging probe can measure a gastric cancer patient’s response to treatment within days, marking a potential breakthrough that could enable patients who aren’t responding to treatment to get moved quickly to potentially more effective therapies
Current imaging modalities show tumor size, but it may take weeks before any perceptible change is demonstrated that can indicate whether the treatment is working. There is a need for new imaging approaches so that patients can be scanned within a few days after receiving treatment to see if it’s working or not.
